AstraZeneca CSPC drug deal: $1.2B for eight drug candidates
The AstraZeneca CSPC drug deal signifies a strategic move by AstraZeneca to expand its portfolio through acquisition of eight drug candidates from CSPC for
Most important news & global events daily
The AstraZeneca CSPC drug deal signifies a strategic move by AstraZeneca to expand its portfolio through acquisition of eight drug candidates from CSPC for
Your cart is currently empty!
Notifications